Delving into the Nutraceutical Benefits of Purple Carrot against Metabolic Syndrome and Cancer: A Review
Type
Journal article
Language
English
Date issued
2022
Author
Rasheed, Hina
Shehzad, Maham
Rabail, Roshina
Jeżowski, Paweł
Ranjha, Muhammad Modassar Ali Nawaz
Rakha, Allah
Din, Ahmad
Aadil, Rana Muhammad
Faculty
Wydział Nauk o Żywności i Żywieniu
Journal
Applied Sciences (Switzerland)
ISSN
2076-3417
Web address
Volume
12
Number
6
Pages from-to
art. 3170
Abstract (EN)
Metabolic syndrome (MetS) constitutes a group of risk factors that may increase the risk of cancer and other health problems. Nowadays, researchers are focusing on food compounds that could prevent many chronic diseases. Thus, people are shifting from dietary supplements towards healthy nutritional approaches. As a nutritious and natural food source, purple carrot (Daucus carota spp. Sativus var. atrorubens Alef.) roots could have an important role in the prevention of MetS as well as cancer. This review provides deep insight into the role of purple carrot’s main bioactive compounds and their effectiveness against MetS and cancer. Phenolic compounds, such as anthocyanin, present in purple carrot roots may be especially productive in avoiding or delaying the onset of cardiovascular disease (CVDs), obesity, diabetes, and cancer. Anthocyanins and other phenolics are successful in reducing metabolic changes and inflammation by inhibiting inflammatory effects. Many researchers have made efforts to employ this vegetable in the prevention and treatment of MetS and cancer. However, more advanced studies are required for the identification of its detailed role, effectiveness, suitable intake, and the effect of its bioactive compounds against these diseases.
License
CC-BY - Attribution
Open access date
March 20, 2022